Urovant Sciences Competitors and Similar CompaniesClear all

Astellas Pharma's competitors and similar companies include Kymera Therapeutics.
Astellas Pharma
Astellas Pharma
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
Kymera Therapeutics
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Founding Date
Founding Date
1923
Founding Date
2017
Type
Type
Public
Type
Public
Tags
Locations
Locations
Tokyo, JP HQ
Macquarie Park, AU
Wien, AT
Vilvoorde, BE
São Paulo, BR
Markham, CA
Beijing, CN
see more
Locations
Watertown, US HQ
Cambridge, US
Employees
Employees
14,754
Employees
207
Valuation ($)
Valuation ($)
20.8 b
Valuation ($)
3.1 b

Financial

Revenue (est.)
Revenue (est.)
¥2.1t (FY, 2026)
Revenue (est.)
$39.2m (FY, 2025)
Cost of goods
Cost of goods
¥213.8b (FY, 2026)
Cost of goods
$39.2m (FY, 2025)
Gross profit
Gross profit
¥2t (FY, 2026)
Gross profit
N/A
Net income
Net income
¥291.6b (FY, 2026)
Net income
($311.4m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Kymera Therapeutics
HQ
Watertown, US
Employees
207

Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.

View company